Why the study?
Does intracerebroventricular blockade of AT1 and/or AT2 receptors alter the reflex regulation of epinephrine release during insulin-induced hypoglycemia in conscious rats?
Does intracerebroventricular blockade of AT1 and/or AT2 receptors alter the reflex regulation of epinephrine release during insulin-induced hypoglycemia in conscious rats?
Brain angiotensin receptors are not essential for reflex epinephrine release during hypoglycemia, but AT2 receptor blockade increases the gain of baroreceptor-mediated bradycardia.
AT2 blockade augments baroreflex bradycardia during hypoglycemia in rats; leaves open translation to human autonomic control.
Simultaneous blockade of systemic AT1 and AT2 receptors or converting enzyme inhibition (CEI) attenuates the hypoglycemia-induced reflex increase of epinephrine (Epi). To examine the role of brain AT1 and AT2 receptors in the reflex regulation of Epi release, we measured catecholamines, hemodynamics, and renin during insulin-induced hypoglycemia in conscious rats pretreated intracerebroventricularly with losartan, PD-123319, losartan and PD-123319, or vehicle. Epi and norepinephrine (NE) increased 60-and 3-fold, respectively. However, the gain of the reflex increase in plasma Epi (Deltaplasma Epi/Deltaplasma glucose) and the overall Epi and NE responses were similar in all groups. The ensuing blood pressure response was similar between groups, but the corresponding bradycardia was augmented after PD-123319 (P < 0.05 vs. vehicle) or combined losartan and PD-123319 (P < 0.01 vs. vehicle). The findings indicate 1) brain angiotensin receptors are not essential for the reflex regulation of Epi release during hypoglycemia and 2) the gain of baroreceptor-mediated bradycardia is increased by blockade of brain AT2 receptors in this model.
No takes yet. Share an insight, caveat, or question.
Worck et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: